# IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study

> **NCT00883584** · PHASE2 · UNKNOWN · sponsor: **Institute of Medicinal Molecular Design, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** IMD-1041
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00883584
- **Lead sponsor:** Institute of Medicinal Molecular Design, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883584, "IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00883584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*